{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:24:45Z","timestamp":1790717085979,"version":"4.1.0"},"reference-count":43,"publisher":"The Journal of Rheumatology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>Systemic sclerosis (SSc) is a disease of autoimmunity, fibrosis, and vasculopathy. Scleroderma renal crisis (SRC) is one of the most severe complications. Corticosteroid exposure, presence of anti-RNA polymerase III antibodies (ARA), skin thickness, and significant tendon friction rubs are among the known risk factors at SSc diagnosis for developing future SRC. Identification of additional clinical characteristics and laboratory findings could expand and improve the risk profile for future SRC at SSc diagnosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>In this retrospective cohort study of the entire military electronic medical record between 2005 and 2016, we compared the demographics, clinical characteristics, and laboratory results at SSc diagnosis for 31 cases who developed SRC after SSc diagnosis to 322 SSc without SRC disease controls.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>After adjustment for potential confounding variables, at SSc diagnosis these conditions were all associated with future SRC: proteinuria (p &lt; 0.001; OR 183, 95% CI 19.1\u20131750), anemia (p = 0.001; OR 9.9, 95% CI 2.7\u201336.2), hypertension (p &lt; 0.001; OR 13.1, 95% CI 4.7\u201336.6), chronic kidney disease (p = 0.008; OR 20.7, 95% CI 2.2\u2013190.7), elevated erythrocyte sedimentation rate (p &lt; 0.001; OR 14.3, 95% CI 4.8\u201343.0), thrombocytopenia (p = 0.03; OR 7.0, 95% CI 1.2\u201342.7), hypothyroidism (p = 0.01; OR 2.8, 95% CI 1.2\u20136.7), Anti-Ro antibody seropositivity (p = 0.003; OR 3.9, 95% CI 1.6\u20139.8), and ARA (p = 0.02; OR 4.1, 95% CI 1.2\u201313.8). Three or more of these risk factors present at SSc diagnosis was sensitive (77%) and highly specific (97%) for future SRC. No SSc without SRC disease controls had \u2265 4 risk factors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>In this SSc cohort, we present a panel of risk factors for future SRC. These patients may benefit from close observation of blood pressure, proteinuria, and estimated glomerular filtration rate, for earlier SRC identification and intervention. Future prospective therapeutic studies could focus specifically on this high-risk population.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.171186","type":"journal-article","created":{"date-parts":[[2018,7,15]],"date-time":"2018-07-15T07:25:11Z","timestamp":1531639511000},"page":"85-92","source":"Crossref","is-referenced-by-count":46,"title":["Risk Factors for Future Scleroderma Renal Crisis at Systemic Sclerosis Diagnosis"],"prefix":"10.3899","volume":"46","author":[{"given":"Sarah M.","family":"Gordon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodger S.","family":"Stitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Nee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne T.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dustin J.","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendral R.","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jess D.","family":"Edison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen W.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2018,7,15]]},"reference":[{"key":"2019010716553446000_46.1.85.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0806188"},{"key":"2019010716553446000_46.1.85.2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.131210"},{"key":"2019010716553446000_46.1.85.3","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.semarthrit.2014.12.001","article-title":"Scleroderma renal crisis","volume":"4","author":"Bose","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"2019010716553446000_46.1.85.4","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-133-8-200010170-00010"},{"key":"2019010716553446000_46.1.85.5","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker271"},{"key":"2019010716553446000_46.1.85.6","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/art.30111","article-title":"HLA-DRB1*0407 and *1304 are risk factors for scleroderma renal crisis","volume":"63","author":"Nguyen","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2019010716553446000_46.1.85.7","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.111417"},{"key":"2019010716553446000_46.1.85.8","doi-asserted-by":"publisher","DOI":"10.1002\/art.10589"},{"key":"2019010716553446000_46.1.85.9","doi-asserted-by":"publisher","DOI":"10.1046\/j.1445-5994.2003.00358.x"},{"key":"2019010716553446000_46.1.85.10","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.066985"},{"key":"2019010716553446000_46.1.85.11","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.080806"},{"key":"2019010716553446000_46.1.85.12","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfs317"},{"key":"2019010716553446000_46.1.85.13","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcm052"},{"key":"2019010716553446000_46.1.85.14","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-O"},{"key":"2019010716553446000_46.1.85.15","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e3283588dcf"},{"key":"2019010716553446000_46.1.85.16","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.lpm.2014.02.031","article-title":"Kidney involvement in systemic sclerosis","volume":"43","author":"Steen","year":"2014","journal-title":"Presse Med"},{"key":"2019010716553446000_46.1.85.17","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3527"},{"key":"2019010716553446000_46.1.85.18","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-06-0591"},{"key":"2019010716553446000_46.1.85.19","doi-asserted-by":"crossref","first-page":"431","DOI":"10.7326\/0003-4819-95-4-431","article-title":"Thyroid disease in progressive systemic sclerosis: increased frequency of glandular fibrosis and hypothyroidism","volume":"95","author":"Gordon","year":"1981","journal-title":"Ann Intern Med"},{"key":"2019010716553446000_46.1.85.20","first-page":"S177","article-title":"Anti-SSA\/Ro52 autoantibodies in scleroderma: results of an observational, cross sectional study","volume":"32","author":"Sanchez-Montalva","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"2019010716553446000_46.1.85.21","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1002\/art.39316","article-title":"Interpretation of an extended autoantibody profile in a well-characterized Australian systemic sclerosis (scleroderma) cohort using principal components analysis","volume":"67","author":"Patterson","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2019010716553446000_46.1.85.22","doi-asserted-by":"publisher","DOI":"10.1097\/01.bor.0000144760.37777.fa"},{"key":"2019010716553446000_46.1.85.23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2133.1989.tb01397.x","article-title":"Antibodies to Ro\/SSA detected by ELISA: correlation with clinical features in systemic scleroderma","volume":"121","author":"Bell","year":"1989","journal-title":"Br J Dermatol"},{"key":"2019010716553446000_46.1.85.24","doi-asserted-by":"publisher","DOI":"10.1186\/ar3763"},{"key":"2019010716553446000_46.1.85.25","unstructured":"Military Health System and the Defense Health Agency . Military Health System review final report 2014. [Internet. Accessed June 4, 2018.] Available from: www.health.mil\/Military-Health-Topics\/Access-Cost-Quality-and-Safety\/MHS-Review"},{"key":"2019010716553446000_46.1.85.26","doi-asserted-by":"crossref","first-page":"142","DOI":"10.7205\/MILMED-D-12-00168","article-title":"Leveraging the military health system as a laboratory for health care reform","volume":"178","author":"Dorrance","year":"2013","journal-title":"Mil Med"},{"key":"2019010716553446000_46.1.85.27","doi-asserted-by":"publisher","DOI":"10.1002\/art.38098"},{"key":"2019010716553446000_46.1.85.28","doi-asserted-by":"crossref","unstructured":"Hosmer DW Lemeshow S Sturdivant RX . Applied logistic regression. 3rd ed. Hoboken, New Jersey: John Wiley & Sons Inc.; 2013:157\u201360.","DOI":"10.1002\/9781118445112.stat06902"},{"key":"2019010716553446000_46.1.85.29","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(84)90986-0"},{"key":"2019010716553446000_46.1.85.30","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-198311000-00001"},{"key":"2019010716553446000_46.1.85.31","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.8777"},{"key":"2019010716553446000_46.1.85.32","first-page":"649","article-title":"Kidney disease other than renal crisis in patients with diffuse scleroderma","volume":"32","author":"Steen","year":"2005","journal-title":"J Rheumatol"},{"key":"2019010716553446000_46.1.85.33","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007101065"},{"key":"2019010716553446000_46.1.85.34","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010091001"},{"key":"2019010716553446000_46.1.85.35","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006050517"},{"key":"2019010716553446000_46.1.85.36","doi-asserted-by":"crossref","unstructured":"Shanmugam VK Steen VD . Renal manifestations in scleroderma: evidence for subclinical renal disease as a marker of vasculopathy. Int J Rheumatol 2010;1\u20138.","DOI":"10.1155\/2010\/538589"},{"key":"2019010716553446000_46.1.85.37","doi-asserted-by":"crossref","first-page":"881","DOI":"10.7326\/0003-4819-89-6-881","article-title":"The kidney in progressive systemic sclerosis","volume":"89","author":"Kovalchik","year":"1978","journal-title":"Ann Intern Med"},{"key":"2019010716553446000_46.1.85.38","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-113-5-352"},{"key":"2019010716553446000_46.1.85.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2013.09.008"},{"key":"2019010716553446000_46.1.85.40","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1053\/j.ajkd.2013.04.016","article-title":"Endothelin receptor antagonism-based treatment for scleroderma renal crisis","volume":"62","author":"Izzedine","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"2019010716553446000_46.1.85.41","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hct111"},{"key":"2019010716553446000_46.1.85.42","first-page":"31","article-title":"Pulmonary hypertension in systemic sclerosis: prevalence, incidence and predictive factors in a large multicentric Italian cohort","volume":"31","author":"Iudici","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"2019010716553446000_46.1.85.43","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.autrev.2017.02.012","article-title":"Towards developing criteria for scleroderma renal crisis: A scoping review","volume":"16","author":"Baron","year":"2017","journal-title":"Autoimmunity Reviews"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.171186","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,20]],"date-time":"2019-10-20T17:12:52Z","timestamp":1571591572000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.171186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,15]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,1]]},"published-print":{"date-parts":[[2019,1]]}},"alternative-id":["10.3899\/jrheum.171186"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.171186","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,15]]}}}